Bone Therapeutics
Founded Year
2006Stage
IPO | IPOTotal Raised
$31.91MDate of IPO
2/5/2015About Bone Therapeutics
Bone Therapeutics is an international biotechnology company that specializes in the treatment of osteoarticular diseases using cell therapy. With its cell technology platform, the company is developing cell products for the repair and regeneration of bone and joint tissues. The company was founded in 2006 and is based in Gosselles, Belgium.
Bone Therapeutics's Product Videos
Compete with Bone Therapeutics?
Ensure that your company and products are accurately represented on our platform.
Bone Therapeutics's Products & Differentiators
ALLOB
Allogeneic bone cell therapy
Expert Collections containing Bone Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Bone Therapeutics is included in 2 Expert Collections, including Regenerative Medicine.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Bone Therapeutics Patents
Bone Therapeutics has filed 17 patents.
The 3 most popular patent topics include:
- Stem cells
- Transcription factors
- Clusters of differentiation
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/26/2013 | 10/4/2022 | Dosage forms, Rare diseases, Drug delivery devices, Orthopedic surgical procedures, Cell biology | Grant |
Application Date | 9/26/2013 |
|---|---|
Grant Date | 10/4/2022 |
Title | |
Related Topics | Dosage forms, Rare diseases, Drug delivery devices, Orthopedic surgical procedures, Cell biology |
Status | Grant |
Latest Bone Therapeutics News
Mar 12, 2023
Partager - 12 conseils Tout juste cotée sur Euronext Bruxelles et Paris, la biotech belge réunit... Tout juste cotée sur Euronext Bruxelles et Paris, la biotech belge, Bone Therapeutics basée à Gosselies, dans le sud de Bruxelles, lèvera finalement 37 M€, après exercice de l’option de sur-allocation. En effet, 301 875 nouvelles actions seront émises au prix unitaire de 16 euros, correspondant à un montant de 4,8 M€. Fondée en 2006 cette biotech est leader dans le développement de produits de thérapie cellulaire destinés à la réparation et à la prévention des fractures. C'est la deuxième (...) Cet article est réservé à nos abonnés. 79% reste à lire Pour accéder à cet article, à l'ensemble du site ainsi qu'à nos bases de données, découvrez nos formules d'abonnement .
Bone Therapeutics Frequently Asked Questions (FAQ)
When was Bone Therapeutics founded?
Bone Therapeutics was founded in 2006.
Where is Bone Therapeutics's headquarters?
Bone Therapeutics's headquarters is located at rue Auguste Piccard, 37, Gosselies.
What is Bone Therapeutics's latest funding round?
Bone Therapeutics's latest funding round is IPO.
How much did Bone Therapeutics raise?
Bone Therapeutics raised a total of $31.91M.
Who are the investors of Bone Therapeutics?
Investors of Bone Therapeutics include Societe Regionale d'Investissement de Wallonie, Sambrinvest, BAMS Angel Fund, Life Sciences Research Partners, Nausicaa Ventures and 3 more.
Who are Bone Therapeutics's competitors?
Competitors of Bone Therapeutics include Carmell Therapeutics and 3 more.
What products does Bone Therapeutics offer?
Bone Therapeutics's products include ALLOB and 1 more.
Who are Bone Therapeutics's customers?
Customers of Bone Therapeutics include Link Health Pharma Co., Ltd and Pregene Biopharma Co., Ltd.
Compare Bone Therapeutics to Competitors
EpiBone develops technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts. Its technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. The company was founded in 2013 and is based in Brooklyn, New York.
Wision AI builds Computer Aided Diagnosis (CAD) algorithms and systems in clinical imaging, to improve diagnostic accuracy and effectiveness. With the methodology of mathematical medicine and functional analysis, Wision AI integrates medical knowledge into flexible and scalable models that leverage the most updated CNNs and GPU computing to achieve high sensitivity and specificity in detection/segmentation/measurement in diagnostic imaging. Wision AI is devoted to realizing the clinical value of AI in various clinical settings, such as gastroenterology, ophthalmology, neurology, radiomics, and more.
Precise Light Surgical is a medical device company focused on endoscopic surgery. The company's Flash Vaporization technology provides precision and control for the removal of delicate tissues to improve patient outcomes and reduce surgical risk and downtime while lowering treatment costs.
Diabetes Neuromathix is an AI/Medtech startup building genuinely machine-intelligent artificial pancreas software suitable for the people who need it most: people with 'brittle' type-1 diabetes (T1D), who suffer from large-scale swings in blood glucose levels on a daily basis.
OxyPrem provides sensors and solutions for patients suffering from brain damage. Its medical silicon device monitors the oxygen levels of preterm infants' brains using harmless, noninvasive near-infrared light. The company was founded in 2018 and is based in Zurich, Switzerland.
Omniscient Neurotechnology creates enterprise grade clinical and research solutions applicable to a variety of brain-related disorders, including depression, chronic pain, cancer, bi-polar disorder, Alzheimer’s, dementia, and PTSD.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.